|
Groups
|
Baseline
|
Reperfusion, min
|
|---|
| | |
5
|
30
|
60
|
120
|
|
CON-22 (n=7)
|
11.9±2.3
|
3.8±1.5
|
5.4±1.6
|
6.5±1.9
|
5.8±2.6
|
|
mKHB-22 (n=7)
|
10.2±2.6
|
4.5±2.3
|
6.7±1.6
|
6.1±1.8
|
4.2±1.7
|
|
STH2-22 (n=6)
|
13.2±3.5
|
5.3±2.5
|
6.7±2.2
|
7.5±4.6
|
5.5±2.1
|
|
CON-37 (n=7)
|
12.4±3.2
|
4.1±1.3
|
4.3±1.9
|
4.1±1.7
|
3.8±1.2
|
|
mKHB-37 (n=5)
|
10.4±1.9
|
6.6±4.0
|
6.2±1.7
|
6.3±0.6
|
5.2±1.4
|
|
STH2-37 (n=6)
|
11.2±1.8
|
5.6±3.9
|
4.6±2.1
|
3.3±0.7
|
3.1±0.9
|
- Data are mean ± SD. Group legends in hypothermia series: controls subjected to 180-min ischemia and 120-min reperfusion (CON-22), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-22), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-22). Group legends in normothermia series: controls subjected to 60-min ischemia and 120-min reperfusion (CON-37), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-37), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-37).
